All posts tagged "Incyte Corporation"

FDA Grants Breakthrough Status to Incyte’s Blood Cancer Drug

Incyte Corporation announced on October 29, 2023, that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational drug, INCA033989. This...